EU throws weight behind Pfizer/BioNTech in vaccine drive




In a stinging rebuke to AstraZeneca, the EU has announced plans to negotiate a massive contract extension for Pfizer/BioNTech’s Covid-19 vaccine, saying the bloc had to go with companies that had shown their value in the pandemic.

“We need to focus on technologies that have proven their worth,” said European Commission president Ursula von der Leyen.

She also announced that America’s Pfizer and Germany’s BioNTech would provide the EU with an extra 50 million doses in the second quarter of this year, making up for faltering deliveries of AstraZeneca.

To read the full article by the Irish Examiner, please click here.